Ocular Therapeutix Stock Target Price and Analyst Consensus

OCUL Stock  USD 8.83  0.31  3.64%   
The current analyst and expert consensus on Ocular Therapeutix is Strong Buy, with 5 strong buy opinions. The current projected Ocular Therapeutix target price consensus is 13.13 with 8 analyst opinions. Check out Macroaxis Advice on Ocular Therapeutix to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.
The most common way Ocular Therapeutix analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Ocular Therapeutix executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Ocular Therapeutix. We strongly encourage you to use your own analysis of Ocular Therapeutix to validate this buy or sell advice. Ocular Therapeutix buy-or-sell recommendation module provides average expert sentiment on the projected Ocular Therapeutix target price to derive its highest and lowest estimates based on projected price volatility of 3.4368.
Lowest Forecast
11.95
Highest Forecast
14.57
Target Price
13.13
Gross Profit is expected to rise to about 55.8 M this year, although the value of Pretax Profit Margin will most likely fall to (1.45). At this time, Ocular Therapeutix's Non Currrent Assets Other are quite stable compared to the past year. Long Term Debt is expected to rise to about 78.7 M this year, although the value of Other Liabilities will most likely fall to about 18.3 M.
  
It's important to approach Ocular Therapeutix's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Ocular Therapeutix price targets

Ocular Therapeutix's stock target price is an estimate of its future price, usually made by analysts. Using Ocular Therapeutix's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Ocular Therapeutix's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Ocular Therapeutix's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Ocular Therapeutix Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Ocular Therapeutix is a key component of Ocular Therapeutix valuation and have some predictive power on the future returns of a Ocular Therapeutix.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocular Therapeutix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
5.118.5211.93
Details
Intrinsic
Valuation
LowRealHigh
4.337.7411.15
Details
Naive
Forecast
LowNextHigh
4.638.0411.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.26-0.25-0.23
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested over 60 shares
Business Services Idea
Business Services
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Momentum Idea
Momentum
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Chemicals Idea
Chemicals
Invested over 30 shares
ESG Investing Idea
ESG Investing
Invested few shares
When determining whether Ocular Therapeutix is a strong investment it is important to analyze Ocular Therapeutix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocular Therapeutix's future performance. For an informed investment choice regarding Ocular Stock, refer to the following important reports:
Check out Macroaxis Advice on Ocular Therapeutix to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Ocular Stock please use our How to buy in Ocular Stock guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.